Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kieback, DG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stickeler, E; Therasakvichya, S; Moebus, VJ; Kieback, DG; Runnebaum, IB; Kreienberg, R
      Modulation of soluble CD44 concentrations by hormone and anti-hormone treatment in gynecological tumor cell lines

      ONCOLOGY REPORTS
    2. Runnebaum, IB; Wang-Gohrke, S; Vesprini, D; Kreienberg, R; Lynch, H; Moslehi, R; Ghadirian, P; Weber, B; Godwin, AK; Risch, H; Garber, J; Lerman, C; Olopade, OI; Foulkes, WD; Karlan, B; Warner, E; Rosen, B; Rebbeck, T; Tonin, P; Dube, MP; Kieback, DG; Narod, SA
      Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

      PHARMACOGENETICS
    3. You, ZB; Fischer, DC; Tong, XW; Hasenburg, A; Aguilar-Cordova, E; Kieback, DG
      Coxsackievirus-adenovirus receptor expression in ovarian cancer cell linesis associated with increased adenovirus transduction efficiency and transgene expression

      CANCER GENE THERAPY
    4. Oberhoff, C; Kieback, DG; Wurstlein, R; Deertz, H; Sehouli, J; van Soest, C; Hilfrich, J; Mesrogli, M; von Minckwitz, G; Staab, HJ; Schindler, AE
      Topotecan chemotherapy in patients with breast cancer and brain metastases: Results of a pilot study

      ONKOLOGIE
    5. Kohlberger, P; Gantert, M; Volk-Orlowska, T; Kieback, DG; Gitsch, G
      Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients

      ANTICANCER RESEARCH
    6. Kieback, DG; Fischer, DC
      Gene expression profile in endometrioid endometrial carcinoma

      GYNECOLOGIC ONCOLOGY
    7. Hasenburg, A; Tong, XW; Rojas-Martinez, A; Nyberg-Hoffman, C; Kieback, CC; Kaplan, A; Kaufman, RH; Ramzy, I; Aguilar-Cordova, E; Kieback, DG
      Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer

      CANCER GENE THERAPY
    8. Freund, CTF; Tong, XW; Block, A; Contant, CF; Kieback, DG; Rowley, DR; Lerner, SP
      Adenovirus-mediated suicide gene therapy for bladder cancer: Comparison ofthe cytomegalovirus- and Rous sarcoma virus-promoter

      ANTICANCER RESEARCH
    9. Engehausen, DG; Tong, XW; Oehler, MK; Freund, CT; Schrott, KM; Kieback, DG
      Androgen receptor gene mutations do not occur in ovarian cancer

      ANTICANCER RESEARCH
    10. Wang-Gohrke, S; Chang-Claude, J; Becher, H; Kieback, DG; Runnebaum, IB
      Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50

      CANCER RESEARCH
    11. Hasenburg, A; Ledet, SC; Ardaman, T; Levy, T; Kieback, DG
      Evaluation of lymph nodes in squamous cell carcinoma of the cervix: touch imprint cytology versus frozen section histology

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    12. Tong, XW; Kieback, DG; Ramesh, R; Freeman, SM
      Molecular aspects of ovarian cancer - Is gene therapy the solution?

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    13. Tong, XW; Engehausen, DG; Freund, CTF; Agoulnik, I; Oehler, MK; Kim, TE; Hasenburg, A; Guo, ZS; Contant, CF; Woo, SLC; Kieback, DG
      Comparison of long-term survival of cytomegalovirus promoter versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancer

      HYBRIDOMA
    14. Moser, PL; Kieback, DG; Hefler, L; Tempfer, C; Neunteufel, W; Gitsch, G
      Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer

      ANTICANCER RESEARCH
    15. Hasenburg, A; Tong, XW; Rojas-Martinez, A; Nyberg-Hoffman, C; Kieback, CC; Kaplan, AL; Kaufman, RH; Ramzy, I; Aguilar-Cordova, E; Kieback, DG
      Thymidine kinase (TK) gene therapy of solid tumors: Valacyclovir facilitates outpatient treatment

      ANTICANCER RESEARCH
    16. Kohlberger, PD; Breitenecker, F; Kaider, A; Losch, A; Gitsch, G; Breitenecker, G; Kieback, DG
      Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: A comparison

      ANTICANCER RESEARCH
    17. Moser, PL; Hefler, L; Tempfer, C; Neunteufel, W; Kieback, DG; Gitsch, G
      Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer

      ANTICANCER RESEARCH
    18. Wang-Gohrke, S; Weikel, W; Risch, H; Vesprini, D; Abrahamson, J; Lerman, C; Godwin, A; Moslehi, R; Olipade, O; Brunet, JS; Stickeler, E; Kieback, DG; Kreienberg, R; Weber, B; Narod, SA; Runnebaum, IB
      Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

      BRITISH JOURNAL OF CANCER
    19. Kohlberger, PD; Stani, J; Gitsch, G; Kieback, DG; Breitenecker, G
      Comparative evaluation of seven cell collection devices for cervical smears

      ACTA CYTOLOGICA
    20. KOHLBERGER PD; JOURA EA; BANCHER D; GITSCH G; BREITENECKER G; KIEBACK DG
      EVIDENCE OF ANDROGEN RECEPTOR EXPRESSION IN LICHEN-SCLEROSUS - AN IMMUNOHISTOCHEMICAL STUDY

      Journal of the Society for Gynecologic Investigation
    21. LEVY T; AGOULNIK I; ATKINSON EN; TONG XW; GAUSE HM; HASENBURG A; RUNNEBAUM I; STICKELER E; MOBUS VJ; KAPLAN AL; KIEBACK DG
      TELOMERE LENGTH IN HUMAN WHITE BLOOD-CELLS REMAINS CONSTANT WITH AGE AND IS SHORTER IN BREAST-CANCER PATIENTS

      Anticancer research
    22. TONG XW; ENGEHAUSEN DG; KAUFMAN RH; AGOULNIK I; CONTANT C; FREUND CTF; OEHLER MK; KIM TE; HASENBURG A; WOO SLC; KIEBACK DG
      IMPROVEMENT OF GENE-THERAPY FOR OVARIAN-CANCER BY USING ACYCLOVIR INSTEAD OF GANCICLOVIR IN ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE-THERAPY

      Anticancer research
    23. TONG XW; ENGEHAUSEN DG; FREUND CTF; AGOULNIK I; GUO ZS; OEHLER MK; KIM TE; HASENBURG A; CONTANT CF; WOO SLC; KIEBACK DG
      THE EFFICACY OF ADENOVIRUS-MEDIATED GENE-THERAPY OF OVARIAN-CANCER ISENHANCED BY USING THE CYTOMEGALOVIRUS PROMOTER

      Anticancer research
    24. Tong, XW; Shine, DH; Agoulnik, I; Freund, CTF; Hasenburg, A; Aguilar-Cordova, E; Woo, SLC; Kieback, DG
      Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents

      ANTICANCER RESEARCH
    25. MOBUS VJ; MOLL R; GERHARZ CD; KIEBACK DG; MERK O; RUNNEBAUM IB; LINNER S; DREHER L; GRILL HJ; KREIENBERG R
      DIFFERENTIAL CHARACTERISTICS OF 2 NEW TUMORIGENIC CELL-LINES OF HUMANBREAST-CARCINOMA ORIGIN

      International journal of cancer
    26. AGOULNIK IY; CHO Y; NIEDERBERGER C; KIEBACK DG; COONEY AJ
      CLONING, EXPRESSION ANALYSIS AND CHROMOSOMAL LOCALIZATION OF THE HUMAN NUCLEAR RECEPTOR GENE GCNF

      FEBS letters
    27. KUDELKA AP; LEVY T; VERSCHRAEGEN CF; EDWARDS CL; PIAMSOMBOON S; TERMRUNGRUANGLERT W; FREEDMAN RS; KAPLAN AL; KIEBACK DG; MEYERS CA; JAECKLE KA; LOYER E; STEGER M; MANTE R; MAVLIGIT G; KILLIAN A; TANG RA; GUTTERMAN JU; KAVANAGH JJ
      A PHASE-I STUDY OF TNP-470 ADMINISTERED TO PATIENTS WITH ADVANCED SQUAMOUS-CELL CANCER OF THE CERVIX

      Clinical cancer research
    28. KOHLBERGER PD; KIEBACK DG; MIAN C; WIENER H; KAINZ C; GITSCH G; BREITENECKER G
      NUMERICAL CHROMOSOMAL-ABERRATIONS IN BORDERLINE, BENIGN, AND MALIGNANT EPITHELIAL TUMORS OF THE OVARY - CORRELATION WITH P53 PROTEIN OVEREXPRESSION AND KI-67

      Journal of the Society for Gynecologic Investigation
    29. STICKELER E; MOBUS VJ; KIEBACK DG; KOHLBERGER P; RUNNEBAUM IB; KREIENBERG R
      INTRON-9 RETENTION IN GENE TRANSCRIPTS SUGGESTS INVOLVEMENT OF CD44 IN THE TUMORIGENESIS OF OVARIAN-CANCER

      Anticancer research
    30. STICKELER E; RUNNEBAUM IB; MOBUS VJ; KIEBACK DG; KREIENBERG R
      EXPRESSION OF CD44 STANDARD AND VARIANT ISOFORMS V5, V6 AND V7 IN HUMAN OVARIAN-CANCER CELL-LINES

      Anticancer research
    31. TONG XW; AGOULNIK I; BLANKENBURG K; CONTANT CF; HASENBURG A; RUNNEBAUM IB; STICKELER E; KAPLAN AL; WOO SLC; KIEBACK DG
      HUMAN EPITHELIAL OVARIAN-CANCER XENOTRANSPLANTS INTO NUDE-MICE CAN BECURED BY ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE-THERAPY

      Anticancer research
    32. MOEBUS VJ; STEIN R; KIEBACK DG; RUNNEBAUM IB; SASS G; KREIENBERG R
      ANTITUMOR-ACTIVITY OF NEW ORGANOMETALLIC COMPOUNDS IN HUMAN OVARIAN-CANCER CELL-LINES AND COMPARISON TO PLATIN DERIVATIVES

      Anticancer research
    33. SKINNER SM; LEE VH; KIEBACK DG; JONES LA; KAPLAN AL; DUNBAR BS
      IDENTIFICATION OF A MEIOTICALLY EXPRESSED CARBOHYDRATE ANTIGEN IN OVARIAN-CARCINOMA .1. IMMUNOHISTOCHEMICAL LOCALIZATION

      Anticancer research
    34. SKINNER SM; KIEBACK DG; CHUNN J; JONES LA; METZGER DA; MALINAK LR; DUNBAR BS
      IDENTIFICATION OF A MEIOTICALLY EXPRESSED CARBOHYDRATE ANTIGEN IN OVARIAN-CARCINOMA .2. ASSOCIATION WITH PROTEINS IN TUMORS AND PERITONEAL-FLUID

      Anticancer research
    35. KOHLBERGER PD; KIEBACK DG; BANCHER D; STICKELER E; HEINZL H; GITSCH G; BREITENECKER G; KAINZ C
      IMMUNOHISTOCHEMICAL DETECTION OF CD44 SPLICE VARIANT EXPRESSION IN PREMALIGNANT LESIONS OF THE CERVIX AND BENIGN CERVICAL EPITHELIUM

      Gynecologic oncology
    36. KOHLBERGER PD; KIEBACK DG; BREITENECKER F; LOESCH A; GITSCH G; KAINZ C; BREITENECKER G
      EPITHELIAL AND STROMAL ESTROGEN AND PROGESTERONE-RECEPTOR EXPRESSION IN ENDOMETRIAL CANCER - TRUE COLOR COMPUTER-ASSISTED IMAGE-ANALYSIS VERSUS SUBJECTIVE SCORING

      Gynecologic oncology
    37. KUDELKA AP; VERSCHRAEGEN CF; LEVY T; EDWARDS CL; FISHMAN A; FREEDMAN RS; KAPLAN A; KIEBACK DG; MANTE R; ENDE K; STEGER M; KAVANAGH JJ
      PRELIMINARY-REPORT OF THE ACTIVITY OF DOCETAXEL IN ADVANCED OR RECURRENT SQUAMOUS-CELL CANCER OF THE CERVIX

      Anti-cancer drugs
    38. KIEBACK DG; LEVI T; KOHLBERGER P; FIEDRICH U; PRESS MF; ROSENTHAL HE; MOBUS VJ; RUNNEBAUM IB; TONG XW; TSAI MJ
      CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR (COUP-TF) EXPRESSION IN HUMAN ENDOMETRIAL CANCER CELL-LINES

      Anticancer research
    39. TONG XW; BLOCK A; CHEN SH; WOO SLC; KIEBACK DG
      ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE TRANSDUCTION IN HUMAN EPITHELIAL OVARIAN-CANCER CELL-LINES FOLLOWED BY EXPOSURE TO GANCICLOVIR

      Anticancer research
    40. TONG XW; BLOCK A; CHEN SH; CONTANT CF; AGOULNIK I; BLANKENBURG K; KAUFMAN RH; WOO SLC; KIEBACK DG
      IN-VIVO GENE-THERAPY OF OVARIAN-CANCER BY ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE TRANSDUCTION AND GANCICLOVIR ADMINISTRATION

      Gynecologic oncology
    41. RUNNEBAUM IB; KIEBACK DG; MOBUS VJ; TONG XW; KREIENBERG R
      SUBCELLULAR-LOCALIZATION OF ACCUMULATED P53 IN OVARIAN-CANCER CELLS

      Gynecologic oncology
    42. RUNNEBAUM IB; KOHLER T; STICKELER E; ROSENTHAL HE; KIEBACK DG; KREIENBERG R
      P53 MUTATION IS ASSOCIATED WITH HIGH S-PHASE FRACTION IN PRIMARY FALLOPIAN-TUBE ADENOCARCINOMA

      British Journal of Cancer
    43. KIEBACK DG; BURKE TW
      MODIFIED INSTRUMENTS FOR MOBILIZATION OF THE URETERS AND PARAMETRIAL TRANSSECTION DURING RADICAL HYSTERECTOMY

      Annals of surgical oncology
    44. GARRETT E; ROWE SM; COUGHLAN SJ; HORAN R; MCLINDEN J; CARNEY DN; FANNING M; KIEBACK DG; HEADON DR
      MENDELIAN INHERITANCE OF A TAQI RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM DUE TO AN INSERTION IN THE HUMAN PROGESTERONE-RECEPTOR GENE AND ITS ALLELIC IMBALANCE IN BREAST-CANCER

      Cancer research, therapy & control
    45. RUNNEBAUM IB; MAIER S; TONG XW; ROSENTHAL HE; MOBUS VJ; KIEBACK DG; KREIENBERG R
      HUMAN PAPILLOMAVIRUS INTEGRATION IS NOT ASSOCIATED WITH ADVANCED EPITHELIAL OVARIAN-CANCER IN GERMAN PATIENTS

      Cancer epidemiology, biomarkers & prevention
    46. RUNNEBAUM IB; TONG XW; KONIG R; HONG Z; KORNER K; ATKINSON EN; KREIENBERG R; KIEBACK DG
      P53-BASED BLOOD-TEST FOR P53PIN3 AND RISK FOR SPORADIC OVARIAN-CANCER

      Lancet
    47. KIEBACK DG; PRESS MF; MCCAMANT SK; ATKINSON EN; MOBUS VJ; RUNNEBAUM IB; KREIENBERG R; JONES LA
      PROGNOSTIC DIFFERENTIATION OF OVARIAN CAR CINOMAS BY IMMUNOHISTOCHEMICAL ANALYSIS OF ESTROGEN-RECEPTOR EXPRESSION

      Geburtshilfe und Frauenheilkunde
    48. MOBUS VJ; RUNNEBAUM J; KIEBACK DG; KREIENBERG R
      THE SPECIAL CASE - VAGINAL FOREIGN-BODY ( FORCEPS) AS A CHANCE FINDING DURING A PRIMARY OPERATION OF BREAST-CARCINOMA

      Geburtshilfe und Frauenheilkunde
    49. ROWE SM; COUGHLAN SJ; MCKENNA NJ; GARRETT E; KIEBACK DG; CARNEY DN; HEADON DR
      OVARIAN CARCINOMA-ASSOCIATED TAQI RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM IN INTRON-G OF THE PROGESTERONE-RECEPTOR GENE IS DUE TO AN ALU SEQUENCE INSERTION

      Cancer research
    50. MCKENNA NJ; KIEBACK DG; CARNEY DN; FANNING M; MCLINDEN J; HEADON DR
      A GERMLINE TAQI RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM IN THE PROGESTERONE-RECEPTOR GENE IN OVARIAN-CARCINOMA

      British Journal of Cancer
    51. RUNNEBAUM IB; TONG XW; MOEBUS V; HEILMANN V; KIEBACK DG; KREIENBERG R
      MULTIPLEX PCR SCREENING DETECTS SMALL P53 DELETIONS AND INSERTIONS INHUMAN OVARIAN-CANCER CELL-LINES

      Human genetics
    52. RUNNEBAUM IB; YEE JK; KIEBACK DG; SUKUMAR S; FRIEDMANN T
      WILD-TYPE P53 SUPPRESSES THE MALIGNANT PHENOTYPE IN BREAST-CANCER CELLS CONTAINING MUTANT P53 ALLELES

      Anticancer research
    53. RUNNEBAUM IB; TONG XW; MOBUS VJ; KIEBACK DG; ROSENTHAL HE; KREIENBERG R
      P53 MUTANT HIS(175) IDENTIFIED IN A NEWLY ESTABLISHED FALLOPIAN-TUBE CARCINOMA CELL-LINE SECRETING INTERLEUKIN-6

      FEBS letters
    54. MOBUS VJ; MOLL R; GERHARZ CD; KIEBACK DG; WEIKEL W; HOFFMANN G; KREIENBERG R
      ESTABLISHMENT OF NEW OVARIAN AND COLON-CARCINOMA CELL-LINES - DIFFERENTIATION IS ONLY POSSIBLE BY CYTOKERATIN ANALYSIS

      British Journal of Cancer
    55. RUNNEBAUM IB; KIEBACK DG; TONG XW; KREIENBERG R
      P53 GAIN-OF-FUNCTION MUTATION IN CODON-175 IS A RARE EVENT IN HUMAN BREAST-CANCER

      Human molecular genetics
    56. RUNNEBAUM IB; KIEBACK DG; FRIEDMANN T; SUKUMAR S; KREIENBERG R
      MUTATIONS OF THE P52 TUMOR-SUPPRESSOR GEN E IN BREAST-CANCER AND SUPPRESSION OF THE NEOPLASTIC PHENOTYPE USING WILD-TYPE P53

      Archives of gynecology and obstetrics
    57. KIEBACK DG; RUNNEBAUM IB; MCCAMANT SK; ATKINSON EN; JONAS LA; KREIENBERG R
      COMPOSITION-ADJUSTED RECEPTOR LEVEL OF TH E ESTROGEN-RECEPTOR FACILITATES INDIVIDUAL PROGNOSIS OF SEROUS OVARIAN-CANCER

      Archives of gynecology and obstetrics
    58. KIEBACK DG; PRESS MF; ATKINSON EN; EDWARDS GL; MOBUS VJ; RUNNEBAUM IB; KREIENBERG R; JONES LA
      PROGNOSTIC-SIGNIFICANCE OF ESTROGEN-RECEPTOR EXPRESSION IN OVARIAN-CANCER - IMMUNOREACTIVE SCORE (IRS) VS COMPOSITION ADJUSTED RECEPTOR LEVEL (CARL)

      Anticancer research
    59. KIEBACK DG; RUNNEBAUM IB; MOEBUS VJ; KREIENBERG R; MCCAMANT SK; EDWARDS CL; JONES LA; TSAI MJ; OMALLEY BW
      CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR (COUP-TF) - AN ORPHAN STEROID-RECEPTOR WITH A SPECIFIC PATTERN OF DIFFERENTIAL EXPRESSION IN HUMAN OVARIAN-CANCER CELL-LINES

      Gynecologic oncology
    60. KIEBACK DG; MCCAMANT SK; PRESS MF; ATKINSON EN; GALLAGER HS; EDWARDS CL; HAJEK RA; JONES LA
      IMPROVED PREDICTION OF SURVIVAL IN ADVANCED ADENOCARCINOMA OF THE OVARY BY IMMUNOCYTOCHEMICAL ANALYSIS AND THE COMPOSITION ADJUSTED RECEPTOR LEVEL OF THE ESTROGEN-RECEPTOR

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 14:55:52